Still, findings from patients with pancreatic cancer suggest that sPD-1 and sPD-L1 are more indicators of systemic inflammation than a reflection of tumoral expression of PD-L1 [98], which could explain the dichotomy compared to the positive predictive role of high tissue PD-L1 expression. The gene discussed is CD274; the disease is pancreatic neoplasm.